Eone Diagnomics Genome Center (245620) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, Eone Diagnomics Genome Center (245620) reported revenue of 7.9 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
20257.9 billion KRW-1.6 billion KRW28.2 billion KRW[source]
202430.9 billion KRW-12.6 billion KRW-95.2 billion KRW[source]
202388.5 billion KRW-9.4 billion KRW-33.0 billion KRW[source]
202294.2 billion KRW-9.5 billion KRW-29.9 billion KRW[source]
202189.3 billion KRW-15.6 billion KRW-20.7 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
202544.1 billion KRW66.5 billion KRW-22.3 billion KRW[source]
202449.2 billion KRW66.5 billion KRW-17.2 billion KRW[source]
2023118.0 billion KRW71.9 billion KRW46.1 billion KRW[source]
2022139.4 billion KRW101.7 billion KRW37.7 billion KRW[source]
2021158.3 billion KRW99.7 billion KRW58.6 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice